Auburn scientist Dr. Gary Piazza is putting a new experimental compound to the test against the most aggressive forms of cancer, including triple negative breast cancer (TNBC).
With BCRFA funding, Auburn University researchers are developing novel treatments for triple-negative breast cancer and overcoming drug resistance in breast cancer cells.
A team of researchers in the Auburn University College of Veterinary Medicine is working to identify and study genetic factors associated with hereditary breast cancer in the African American community.
Dr. Shevde-Samant’s goal is to learn more about how obesity and high blood sugar levels can affect breast cancer and potentially find new ways to treat it. This is especially relevant for Alabama, a state where over 15% of adults have diabetes, and of these 80% are overweight-to-obese.
Since receiving funding from the BCRFA in 2021, Dr. Laura Q. Rogers’ has been hard at work finding ways to improve the health and extend the lives of cancer survivors.
BCRFA provided funds to help purchase and input some of the resources from which the UALCAN site pulls. As of December 2022, the UALCAN data-mining platform has had more than 1,080,000 page views from more than 100 countries.
The BCRFA announced it invested a total of $1,275,000 in Alabama-based breast cancer research this year. The grants will fund 24 research projects at seven institutions across the state,
The BCRFA announced a total investment of $1,225,000 in Alabama-based breast cancer research for 2021. Grants fund 20 research projects across the state.